Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status

The large randomized placebo controlled trials of the Women’s Health Initiative have shown that the combination of estrogen and progestin medroxyprogesterone acetate (MPA) protects from colorectal cancer in postmenopausal women. No effect was observed in women treated with estrogen alone. This sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, Bartolomeus J., Wielenga, Mattheus C.B., Hoyer, Patricia B., Amos-Landgraf, James M., Hakvoort, Theodorus B.M., Muncan, Vanesa, Heijmans, Jarom, van den Brink, Gijs R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078141/
https://www.ncbi.nlm.nih.gov/pubmed/30093969
http://dx.doi.org/10.18632/oncotarget.25703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078141/
https://www.ncbi.nlm.nih.gov/pubmed/30093969
http://dx.doi.org/10.18632/oncotarget.25703

Ejemplares similares